"The Next Step" e-Newsletter: January Edition Momentum continues to build to combat the nation's drug shortage crisis with recent Congressional hearings and the release of a Government Accountability Office (GAO) report and Food and Drug Administration (FDA) interim final rule calling for stronger manufacturer reporting requirements. CCCA has been actively engaged on this issue over the past several months, co-hosting a Capitol Hill briefing, sharing information with advocates, and educating lawmakers and their staff about the breadth and impact of the shortages in drugs vital to the treatment of children with cancer. Read more... |
Notable Recent News:
|